PMID- 16970955 OWN - NLM STAT- MEDLINE DCOM- 20070717 LR - 20111117 IS - 0021-9150 (Print) IS - 0021-9150 (Linking) VI - 192 IP - 2 DP - 2007 Jun TI - Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. PG - 335-41 AB - AIMS: Different epidemiological studies have demonstrated that some ethanol containing beverages intake could be associated with a reduction of cardiovascular mortality, effect attributed in part to its antioxidant properties. Nuclear factor-kappa B (NF-kappaB) is a redox sensitive transcription factor implicated in the pathogenesis of atherosclerosis. We have examined the effect of four different ethanol containing beverages on the activation of NF-kappaB in peripheral blood mononuclear cells (PBMC) and circulating concentrations of monocyte chemoattractant protein-1 (MCP-1) in healthy volunteers receiving a fat-enriched diet. METHODS AND RESULTS: Sixteen volunteers received 16 g/m(2) of ethanol in form of red wine, spirits (vodka, rum, and brandy) or no ethanol intake along with a fat-enriched diet during 5 days and all of them took all alcohols at different periods. NF-kappaB activation (electrophoretic mobility shift assay) and circulating MCP-1 levels (ELISA) were examined in blood samples taken before and after 5 days of ethanol intake. Subjects receiving a fat-enriched diet had increased NF-kappaB activation in PBMC at day 5. Furthermore, MCP-1 levels were increased in plasma at day 5. Red wine intake and some ethanol beverages containing polyphenols (brandy and rum) prevented NF-kappaB activation and decreased MCP-1 release. CONCLUSION: Consumption of moderate amounts of alcoholic drinks containing polyphenols decreases NF-kappaB activation in PBMCs and MCP-1 plasma levels during a fat-enriched diet. Our results provide additional evidence of the anti-inflammatory effects of some ethanol containing beverages, further supporting the idea that its moderate consumption may help to reduce overall cardiovascular mortality. FAU - Blanco-Colio, Luis Miguel AU - Blanco-Colio LM AD - Vascular Research Laboratory, Fundacion Jimenez Diaz, Autonoma University, Avenida Reyes Catolicos 2, Madrid, Spain. FAU - Munoz-Garcia, Begona AU - Munoz-Garcia B FAU - Martin-Ventura, Jose Luis AU - Martin-Ventura JL FAU - Alvarez-Sala, Luis Antonio AU - Alvarez-Sala LA FAU - Castilla, Manuela AU - Castilla M FAU - Bustamante, Ana AU - Bustamante A FAU - Lamuela-Raventos, Rosa Maria AU - Lamuela-Raventos RM FAU - Gomez-Gerique, Juan AU - Gomez-Gerique J FAU - Fernandez-Cruz, Arturo AU - Fernandez-Cruz A FAU - Millan, Jesus AU - Millan J FAU - Egido, Jesus AU - Egido J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060912 PL - Ireland TA - Atherosclerosis JT - Atherosclerosis JID - 0242543 RN - 0 (Anti-Inflammatory Agents) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Dietary Fats) RN - 0 (Flavonoids) RN - 0 (NF-kappa B) RN - 0 (Phenols) RN - 0 (Polyphenols) SB - IM MH - Adult MH - *Alcoholic Beverages MH - Anti-Inflammatory Agents/*pharmacology MH - Chemokine CCL2/*blood MH - Dietary Fats/*administration & dosage MH - Female MH - Flavonoids/*pharmacology MH - Humans MH - Leukocytes, Mononuclear/*drug effects/physiology MH - Male MH - NF-kappa B/drug effects/*metabolism MH - Phenols/*pharmacology MH - Polyphenols EDAT- 2006/09/15 09:00 MHDA- 2007/07/18 09:00 CRDT- 2006/09/15 09:00 PHST- 2006/05/04 00:00 [received] PHST- 2006/07/25 00:00 [revised] PHST- 2006/07/28 00:00 [accepted] PHST- 2006/09/15 09:00 [pubmed] PHST- 2007/07/18 09:00 [medline] PHST- 2006/09/15 09:00 [entrez] AID - S0021-9150(06)00463-1 [pii] AID - 10.1016/j.atherosclerosis.2006.07.035 [doi] PST - ppublish SO - Atherosclerosis. 2007 Jun;192(2):335-41. doi: 10.1016/j.atherosclerosis.2006.07.035. Epub 2006 Sep 12.